Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $368,790 were purchased by GILEAD SCIENCES, INC. on Apr 02 ’24. At $0.76 per share, GILEAD SCIENCES, INC. acquired 485,250 shares. The insider’s holdings grew to 7,345,473 shares worth approximately $485.98 million following the completion of this transaction.
Also, Parsey Merdad sold 2,000 shares, netting a total of over 145,920 in proceeds. Following the sale of shares at $72.96 each, the insider now holds 96,304 shares.
Before that, Parsey Merdad had sold 8,230 shares from its account. In a trade valued at $598,624, the Chief Medical Officer traded Gilead Sciences, Inc. shares for $72.74 each. Upon closing the transaction, the insider’s holdings decreased to 8,230 shares, worth approximately $6.13 million.
As published in a research note from Truist on February 22, 2024, Gilead Sciences, Inc. [GILD] has been rated down from a Buy to a Hold and the price target has been revised to $82 from $91. Analysts at Deutsche Bank started covering the stock with ‘”a Hold”‘ outlook in a report released in early November. As of September 08, 2023, BofA Securities has increased its “Neutral” rating to a “Buy” for GILD. Earlier on September 06, 2023, HSBC Securities initiated its rating. Their recommendation was “a Reduce” for GILD stock.
Analyzing GILD Stock Performance
During the last five days, there has been a drop of approximately -3.63%. Over the course of the year, Gilead Sciences, Inc. shares have dropped approximately -18.33%. Shares of the company reached a 52-week high of $87.86 on 01/19/24 and a 52-week low of $65.90 on 04/18/24. A 50-day SMA is recorded $72.17, while a 200-day SMA reached $76.65. Nevertheless, trading volume fell to 6.44 million shares from 5.29 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc. (GILD)
According to the 24-hour chart, there is a support level at 65.70, which, if violated, would cause prices to drop to 65.24. In the upper region, resistance lies at 66.82. The next price resistance is at 67.48. RSI (Relative Strength Index) is 23.18 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.30, which suggests the price will decrease in the coming days. Percent R is at 96.45%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
